Hot or Cold

MMM stock sentiment today3M Company

Sentiment verdict

Gossip first, financials second — NEUTRAL at 72% confidence.

Last updated · cached analysis, refreshes periodically

NYSE

MMM

3M Company
174.34 USD▼ 2.06%vs. session open
After hours · market closedQuote as of Nov 1, 11:17 AM UTC
Dividend 1.79% yield · 3.12 USD/sh
NEUTRAL72% confidenceSign in to save

A story of massive legal de-risking and a spin-off recovery, balanced by stagnant organic growth and a 'show-me' story for the new CEO.

Analyzed Nov 1, 2026, 06:22 AM UTC·Quote: CNBC / Yahoo Finance·News: Google News·Targets: StockAnalysis.com·AI: Lovable AI (google/gemini-3-flash-preview)
Tone“MMM is NEUTRAL — A story of massive legal de-risking and a spin-off recovery, balanced by stagnant organic growth and a 'show-me' story for the new CEO. 6-month call: USD176.05 (+1.0%).”
6-month price prediction
USD176.05▲ 1.0%by May 2027
80% model confidence
Bear USD144.09Now USD174.34Bull USD208.00
Crowd call · 6 months
No predictions yet

Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.

Make your call as a guest

You'll show up on boards and The Floor under this name. Add an email later to keep your history.

No account needed. You can add an email later to keep your calls.

Already have an account? Sign in

🔒 Full prediction model breakdown

See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.

Sign in to go Pro →

Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for MMM. Not financial advice.

02·a

Price · last 12 months

141.20 – 183.78 USD
Growth
1W
+0.5%
1M
+6.2%
3M
-1.6%
6M
+23.2%
YTD
+7.7%
1Y
+7.5%
01

Gossip

mixed

The narrative has shifted from 'existential legal threat' to 'operational turnaround.' Investors are weighing the recent Solventum spin-off and multi-billion dollar PFAS/Earplug settlements against the potential for Bill Brown to reinvigorate R&D.

  • ·PFAS 'Forever Chemical' liability settlements
  • ·Solventum (healthcare) spin-off completion
  • ·New CEO leadership transition from L3Harris
  • ·Dividend cut normalization post-spin
02

Financial

average

Margins are improving due to aggressive restructuring, but the balance sheet remains burdened by structured legal payouts over the next decade. Revenue growth is sluggish, though cash flow generation remains a core strength.

  • ·Forward P/E ~14x (Historical discount)
  • ·Dividend yield ~1.6% (Post-rebase)
  • ·Free Cash Flow conversion consistently high
  • ·Debt-to-EBITDA elevated due to legal accruals
02b

Conviction

Hollow

Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.

31conviction score / 100

Hollow — insiders are stepping back and the register is short-horizon.

  • ·Insiders sold a net $4.3M on the open market in the last 120 days.
Insider buys (120d)
0
Net insider flow
-$4.3M
Patient capital
—
🔒 Who bought, and who's holding

Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.

Unlock with Pro →

Source: SEC EDGAR Form 4. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.

03

Risks

watch
  • ·Ongoing litigation regarding personal injury for PFAS exposure outside of water providers
  • ·Slowdown in electronics and consumer discretionary end-markets
  • ·Execution risk in right-sizing the company post-spin
05

Analyst price target

HOT
191.92 USD▲ 10.1% vs current

Consensus average of 12 analysts · median 197.00

Low 135.00High 230.00

Source: StockAnalysis.com · updated 2026-10-26

AI-generated analysis for informational purposes only. Not financial advice.